Preliminary Report - ID Mapping
Differences
This shows you the differences between two versions of the page.
| Both sides previous revision Previous revision | Next revision Both sides next revision | ||
|
covid:unpublished [2020/06/02 13:51] biogridadmin |
covid:unpublished [2020/06/02 13:55] biogridadmin |
||
|---|---|---|---|
| Line 30: | Line 30: | ||
| | **888800000023** | **[[https://doi.org/10.1101/2020.04.19.048710|10.1101/2020.04.19.048710]]** | Zhao X (2020) | **[[https://thebiogrid.org/221571/publication|Broad and differential animal ACE2 receptor usage by SARS-CoV-2]]** | | | **888800000023** | **[[https://doi.org/10.1101/2020.04.19.048710|10.1101/2020.04.19.048710]]** | Zhao X (2020) | **[[https://thebiogrid.org/221571/publication|Broad and differential animal ACE2 receptor usage by SARS-CoV-2]]** | | ||
| | **888800000024** | **[[https://doi.org/10.1101/2020.04.26.061705|10.1101/2020.04.26.061705]]** | Viswanathan T (2020) | **[[https://thebiogrid.org/221642/publication|Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus]]** | | | **888800000024** | **[[https://doi.org/10.1101/2020.04.26.061705|10.1101/2020.04.26.061705]]** | Viswanathan T (2020) | **[[https://thebiogrid.org/221642/publication|Structural Basis of RNA Cap Modification by SARS-CoV-2 Coronavirus]]** | | ||
| - | | **888800000025** | **[[https://doi.org/10.1101/2020.04.29.068890|10.1101/2020.04.29.068890]]** | Rut W (2020) | **[[https://thebiogrid.org/221777/publication/activity-profiling-of-sars-cov-2-plpro-protease-provides-structural-framework-for-anti-covid-19-drug-design.html]]** | | + | | **888800000025** | **[[https://doi.org/10.1101/2020.04.29.068890|10.1101/2020.04.29.068890]]** | Rut W (2020) | **[[https://thebiogrid.org/221777/publication|Activity profiling of SARS-CoV-2-PLpro protease provides structural framework for anti-COVID-19 drug design]]** | |
| - | | **888800000026** | **[[https://doi.org/10.1101/2020.04.27.063180|10.1101/2020.04.27.063180]]** | Hillen HS (2020) | **[[https://thebiogrid.org/221778/publication/structure-of-replicating-sars-cov-2-polymerase.html]]** | | + | | **888800000026** | **[[https://doi.org/10.1101/2020.04.27.063180|10.1101/2020.04.27.063180]]** | Hillen HS (2020) | **[[https://thebiogrid.org/221778/publication|Structure of replicating SARS-CoV-2 polymerase]]** | |
| - | | **888800000027** | **[[https://doi.org/10.1101/2020.04.29.068098|10.1101/2020.04.29.068098]]** | Sun Z (2020) | **[[https://thebiogrid.org/221779/publication/mass-spectrometry-analysis-of-newly-emerging-coronavirus-hcov-19-spike-s-protein-and-human-ace2-reveals-camouflaging-glycans-and-unique-post-translational-modifications.html]]** | | + | | **888800000027** | **[[https://doi.org/10.1101/2020.04.29.068098|10.1101/2020.04.29.068098]]** | Sun Z (2020) | **[[https://thebiogrid.org/221779/publication|Mass spectrometry analysis of newly emerging coronavirus HCoV-19 spike S protein and human ACE2 reveals camouflaging glycans and unique post-translational modifications]]** | |
| - | | **888800000028** | **[[https://doi.org/10.1101/2020.05.03.073080|10.1101/2020.05.03.073080]]** | Vuong W (2020) | **[[https://thebiogrid.org/221830/publication/feline-coronavirus-drug-inhibits-the-main-protease-of-sars-cov-2-and-blocks-virus-replication.html]]** | | + | | **888800000028** | **[[https://doi.org/10.1101/2020.05.03.073080|10.1101/2020.05.03.073080]]** | Vuong W (2020) | **[[https://thebiogrid.org/221830/publication|Feline coronavirus drug inhibits the main protease of SARS-CoV-2 and blocks virus replication]]** | |
| - | | **888800000029** | **[[https://doi.org/10.1101/2020.05.02.20086876|10.1101/2020.05.02.20086876]]** | Zhang D (2020) | **[[https://thebiogrid.org/221831/publication/ultra-fast-and-onsite-interrogation-of-severe-acute-respiratory-syndrome-coronavirus-2-sars-cov-2-in-environmental-specimens-via-surface-enhanced-raman-scattering-sers.html]]** | | + | | **888800000029** | **[[https://doi.org/10.1101/2020.05.02.20086876|10.1101/2020.05.02.20086876]]** | Zhang D (2020) | **[[https://thebiogrid.org/221831/publication|Ultra-fast and onsite interrogation of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) in environmental specimens via surface enhanced Raman scattering (SERS)]]** | |
| - | | **888800000030** | **[[https://doi.org/10.1101/2020.05.05.079202|10.1101/2020.05.05.079202]]** | Huo J (2020) | **[[https://thebiogrid.org/221832/publication/neutralization-of-sars-cov-2-by-destruction-of-the-prefusion-spike.html]]** | | + | | **888800000030** | **[[https://doi.org/10.1101/2020.05.05.079202|10.1101/2020.05.05.079202]]** | Huo J (2020) | **[[https://thebiogrid.org/221832/publication|Neutralization of SARS-CoV-2 by destruction of the prefusion Spike]]** | |
| - | | **888800000031** | **[[https://doi.org/10.1101/2020.05.06.079830|10.1101/2020.05.06.079830]]** | Zha L (2020) | **[[https://thebiogrid.org/221833/publication/development-of-a-covid-19-vaccine-based-on-the-receptor-binding-domain-displayed-on-virus-like-particles.html]]** | | + | | **888800000031** | **[[https://doi.org/10.1101/2020.05.06.079830|10.1101/2020.05.06.079830]]** | Zha L (2020) | **[[https://thebiogrid.org/221833/publication|Development of a COVID-19 vaccine based on the receptor binding domain displayed on virus-like particles]]** | |
| - | | **888800000032** | **[[https://doi.org/10.1101/2020.05.02.043554|10.1101/2020.05.02.043554]]** | Gunther S (2020) | **[[https://thebiogrid.org/221835/publication/catalytic-cleavage-of-heat-and-subsequent-covalent-binding-of-the-tetralone-moiety-by-the-sars-cov-2-main-protease.html]]** | | + | | **888800000032** | **[[https://doi.org/10.1101/2020.05.02.043554|10.1101/2020.05.02.043554]]** | Gunther S (2020) | **[[https://thebiogrid.org/221835/publication|Catalytic cleavage of HEAT and subsequent covalent binding of the tetralone moiety by the SARS-CoV-2 main protease]]** | |
| - | | **888800000033** | **[[https://doi.org/10.1101/2020.05.01.20077743|10.1101/2020.05.01.20077743]]** | Wu Y (2020) | **[[https://thebiogrid.org/221836/publication/a-non-competing-pair-of-human-neutralizing-antibodies-block-covid-19-virus-binding-to-its-receptor-ace2.html]]** | | + | | **888800000033** | **[[https://doi.org/10.1101/2020.05.01.20077743|10.1101/2020.05.01.20077743]]** | Wu Y (2020) | **[[https://thebiogrid.org/221836/publication|A non-competing pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2]]** | |
| - | | **888800000034** | **[[https://doi.org/10.1101/2020.05.03.074914|10.1101/2020.05.03.074914]]** | Liu X (2020) | **[[https://thebiogrid.org/221959/publication/neutralizing-antibodies-isolated-by-a-site-directed-screening-have-potent-protection-on-sars-cov-2-infection.html]]** | | + | | **888800000034** | **[[https://doi.org/10.1101/2020.05.03.074914|10.1101/2020.05.03.074914]]** | Liu X (2020) | **[[https://thebiogrid.org/221959/publication|Neutralizing Antibodies Isolated by a site-directed Screening have Potent Protection on SARS-CoV-2 Infection]]** | |